The narcotic antagonist naloxone was tested to determine its possible interaction with N,Ndimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) in adult male Holtzman rats trained to press a bar on a fixed-ratio four schedule (FR4), i.e., every fourth press earned a reward of 0.01ml sugar sweetened milk. LSD (0.1mg/kg) or increasing doses of DMT (1.0, 3.2, and 10.0mg/kg) were administered i.p. to disrupt food-rewarded fixed ratio bar pressing in a dose related fashion. Pretreatment (5-10 min) with behaviorally ineffective doses of naloxone (l.0-5.6mg/kg) dramatically enhanced the effects of DMT and LSD. The content of DMT in the brain and liver of rats injected with DMT alone (10mg/kg) and with a 5min pretreatment of naloxone (3.2 mg/kg) was determined by radiochemical analysis at 30 and 90min after 14C-DMT injection. There was no significant difference for either brain or liver I~C-DMT levels when control DMT rats were compared with the naloxone pretreated rats. These results seem to rule out interference by naloxone with the metabolism of DMT as a mechanism of the observed behavioral potentiation.
Procedure. Rats were trained to press a bar for an hour daily using 0.01 ml of sugar sweetened, water diluted evaporated milk as positive reinforcement. The milk was prepared by combining 400ml of evaporated milk with 400 ml tap water and 60 g of granulated sugar. Daily experiments were conducted in a darkened, isolated room using Lehigh Valley Electronics rodent operant test cages model 143-21. The daily bar-pressing schedule was fixed-ratio four (FR~) i.e., every fourth bar press earned a reward. Cumulative recorders automatically recorded bar presses, reinforcements, and any disruption of normal bar pressing. Upon stabilization of FR4 behavior, each rat was then subjected to a daily schedule of an hour of bar pressing for at least 5 days prior to any injections. The training and testing procedures were similar to those previously described by Kovacic and Domino (1976) . Animals used in the study were drug free for a minimum of 10 days prior to the experiment and had no past drug history of long-acting compounds. Rats served as their own controls to compare the effect of a hallucinogen with and without naloxone pretreatment. All rats were scheduled in randomly assigned groups. Drug-free intervals of 1 week were observed for all pretreatment groups. Because of the short action of DMT, less than a full week was accepted as a drug-free interval for DMT eontroi groups. Doses of DMT (1.0, 3.2, and 10.0mg/kg) or LSD (0.1 mg/kg) were administered i.p. to disrupt food-rewarded fixed ratio bar pressing in a dose related fashion. Log doses of naloxone (1.0, 2.4, 3.2, and 5.6mg/kg), which had demonstrated no effect on normal bar pressing behavior for periods up to 60 rain, were used as pretreatment doses. No 0.9 % NaC1 pretreatments were used for control hallucinogen reactions since it had previously been demonstrated that saline pretreatment does not alter reactions to DMT or LSD (Kovacic and Domino, 1976; Kovacic et al., 1978) .
In the control procedure, rats were placed in an operant chamber for 15 min of bar pressing, injected with the hallucinogen (i.p.), and returned immediately to the operant chamber until the rat recovered and bar pressed at a rate of 90 % of control for a 60 rain period. Animals were observed and behavior was noted for the duration of the drug effect.
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For the pretreatment procedure, rats were pretreated with w "E naloxone (i.p.) and immediately placed in the operant chamber to bar 05 -M press for 5-10 min, injected with the hallucinogen (i.p.), and returned immediately to the operant chamber until the rat recovered _z zloand bar pressed steadily for 60 min or more. Animals were observed o~ ta and behavior was noted for the duration of the drug effect, no_ I8O-Data Analysis. The duration of the drug effect was measured by the horizontal line generated by the cumulative recorder during the co cessation of normal bar pressing. Since both onset and recovery of ~ 150-DMT and LSD effects are sudden and complete, the duration of the z o drug effect could easily be calculated from the length of the horizontal ~ Izo. segment. To statistically analyze this data, two-tailed Student t-tests O3 were calculated according to Snedecor (1956) using the value of P w < 0.05 as significant. ~ 90.
Drugs. Naloxone hydrochloride was administered in 0,9 % NaC1; z concentrations refer to free base. DMT doses refer to free base; __Q 60-solutions were prepared by dissolving the free base in I N HC1, adding a: 0.9 % NaC1, and adjusting the pH with 0.1 N NaOH, rendering the D final volume at a pH of 4.5 -6.0. Doses of LSD refer to LSD-25 salt.
~c~ 3o-Naloxone was obtained courtesy of the Endo Laboratories. DMT ,~, was obtained from the Sigma Chemical Company. LSD (Delysid) substance was obtained from the National Institute on Drug Abuse.
Chemical Methods. Male Holtzman rats, unfasted, weighing approximately 500 g were used for chemical analysis. Pretreated rats were injected with naloxone 3.2 mg/kg (i.p.) 5 rain prior to 14C-DMT 10mg/3gCi/kg (i.p.). Control rats received only t~C-DMT I0 rag/3 l~Ci/kg (i.p.). The rats were sacrificed by guillotine at 30 rain and 90min after the ~4C-DMT injection. The entire brain and approximately 2 g of liver from each rat were immediately removed and homogenized in ice cold 1 N HC1. The homogenates were assayed for total radioactivity, total acidic metabolites, and DMT (as previously described in Lu et al., 1974 Lu et al., , 1978 . N,N,-Dimethyltryptamine side chain-l-~4C-hydrogen oxalate was purchased from New England Nuclear, Boston, MA. The ~4C-DMT 10 mg/3 gCi/ml solution was prepared by mixing nonradioactive DMT with radioactive DMT. 2~,o. Fig. 2 with pretreatment of naloxone (3.2 mg/kg, i.p.) 5 min prior to DMT. To determine whether naloxone was interferring with the metabolism of DMT, rat brain and liver were assayed for 14C-DMT. When control untrained groups of rats were compared to naloxone pretreated groups, analyzed by group comparison Student t-tests, no significant differences were found in brain or liver DMT or acid metabolite content as shown in Fig. 3 . Discussion N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) are substances used as models for the study of psychosis as they mimic schizophrenia in many aspects (Gillin et al., 1976; Fischer, 1974; Appel and Freedman, 1965; Wyatt et al., 1973 Wyatt et al., , 1974 Jacobsen, 1963; Domino, 1975) . DMT has been postulated and sometimes identified as being an endogenous substance (Lu et al., 1974; Corbett et al., 1978; Appel and Freedman, 1965; Narasimhachari et al., 1971; Vogel and Evans, 1977; Oon et al., 1977; Lord et al., 1977; Bloom et al., 1976; Marx, 1976; Angrist et al., 1976) . Similarly, an endogenous ligand of a putative LSD-serotonin receptor has been described in the cerebrospinal fluid of unmedicated psychotic patients (Mehl et al., 1977) . Naloxone has been reported to reduce the auditory hallucinations in some schizophrenic patients (Gunne et al., 1977; Terenius et al., 1977; Watson et al., 1978) but has also been ineffective in other cases (Gitlin and Rosenblatt, 1978; Janowsky et al., 1977a, b; Davis et al., 1977) . These and other reports of enhanced opiate-like material in the cerebrospinal fluid have raised speculations regarding an abnormal endogenous opiate associated with mental disease. Fertziger and Fischer (1977) have described that LSD induced in rats a diphasic reaction consisting of an initial excitatory phase and a prolonged catalepsy phase. Naloxone given after LSD antagonized the cataleptic phase, but when given as a pretreatment shortened the excitation and prolonged the cataleptic response. Their findings, as well as those of Belluzzi et al. (1976) , that naloxone can antagonize enkephalininduced analgesia, suggests an interaction among naloxone, LSD, and endogenous opiates. Our data, demonstrating that t4C-DMT levels are not altered by naloxone, strengthen this possibility. Nevertheless, other possibilities which do not implicate endogenous opiates must be excluded prior to considering this hypothesis seriously. At least in the case of DMT, it appears that altered DMT levels are not involved in the naloxone enhancement of DMT behavioral depression. It is to be emphasized that the dose of naloxone used which enhances the actions of both DMT and LSD alone does not alter the FR 4 behavior, although much larger doses of naloxone alone are disrupting.
